Letter/Communication
Fitusiran: A Potential Option for Patients with Hemophilia A or B, with or Without Inhibitors
NEJM journal watch. Oncology & hematology
04/21/2023
Abstract
This investigational siRNA-based therapy shows promise in reducing bleeding episodes in males with severe hemophilia A or B with or without inhibitors and without thrombophilia.
Details
- Title: Subtitle
- Fitusiran: A Potential Option for Patients with Hemophilia A or B, with or Without Inhibitors
- Creators
- Anjali Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM journal watch. Oncology & hematology
- Publisher
- Massachusetts Medical Society
- ISSN
- 2330-0426
- Language
- English
- Date published
- 04/21/2023
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984399499902771
Metrics
8 Record Views